Tech Company Financing Transactions

Vascular Therapies Funding Round

Private investors participated in a $2.7 million funding round for Vascular Therapies. The financing round was announced on 7/14/2013.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Medical Devices & Instruments
Mailing Address
105 Union Ave.
Cresskill, NJ 07626
Email Address
Vascular Therapies LLC is a medical device company developing an innovative drug-device combination product to address vascular bypass failure in Arterio-venous graft (AVG), Arterio-venous fistula (AVF), Peripheral arterial bypass graft (PABG) and Coronary artery bypass graft (CABG) procedures.
Vascular Therapies LinkedIn Company Profile
Social Media
Vascular Therapies Company Twitter Account
Company News
Vascular Therapies News
Vascular Therapies on Facebook
Vascular Therapies on YouTube

Management Team

Email & Social
Chief Executive Officer
John McDermott
  John McDermott LinkedIn Profile  John McDermott Twitter Account  John McDermott News  John McDermott on Facebook
Chief Scientific Officer
Sriram Iyer
  Sriram Iyer LinkedIn Profile  Sriram Iyer Twitter Account  Sriram Iyer News  Sriram Iyer on Facebook
VP - Manufacturing
Ronald Eggan
  Ronald Eggan LinkedIn Profile  Ronald Eggan Twitter Account  Ronald Eggan News  Ronald Eggan on Facebook
VP - Operations
Rosanne Terraciano
  Rosanne Terraciano LinkedIn Profile  Rosanne Terraciano Twitter Account  Rosanne Terraciano News  Rosanne Terraciano on Facebook
VP - Product Management
Paul Barkofsky
  Paul Barkofsky LinkedIn Profile  Paul Barkofsky Twitter Account  Paul Barkofsky News  Paul Barkofsky on Facebook
VP - Regulatory Affairs
Maureen Harrison
  Maureen Harrison LinkedIn Profile  Maureen Harrison Twitter Account  Maureen Harrison News  Maureen Harrison on Facebook
VP - Regulatory Affairs
Rakesh Raghubanshi
  Rakesh Raghubanshi LinkedIn Profile  Rakesh Raghubanshi Twitter Account  Rakesh Raghubanshi News  Rakesh Raghubanshi on Facebook



Browse more venture capital transactions:

Prev: 7/14/2013: Cytogel Pharma venture capital transaction
Next: 7/14/2013: Zenverge venture capital transaction


Share this article


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary